Over-the-counter drug · UNAPPROVED HOMEOPATHIC
Cell Salt Combination 8013 (cell salt combination) NDC 63083-8013
Anhydrous dibasic calcium phosphate 6 [hp_X]/59mL + 11 more ingredients · Liquid · Oral · Professional Complementary Health Formulas
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 63083-8013-2 | 63083801302 | 59 mL in 1 BOTTLE, DROPPER (63083-8013-2)Marketed from Aug 15, 1985 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Cell Salt Combination 8013Suffix: 8013
- Generic name (nonproprietary)
- cell salt combination
- Active ingredients
- Anhydrous dibasic calcium phosphate — 6 [hp_X]/59mLPotassium chloride — 6 [hp_X]/59mLCalcium sulfate anhydrous — 6 [hp_X]/59mLFerrosoferric phosphate — 6 [hp_X]/59mLCalcium fluoride — 6 [hp_X]/59mLPotassium phosphate, Unspecified form — 6 [hp_X]/59mLSodium chloride — 6 [hp_X]/59mLPotassium sulfate — 6 [hp_X]/59mLMagnesium phosphate, Dibasic trihydrate — 6 [hp_X]/59mLSodium phosphate, Dibasic, Heptahydrate — 6 [hp_X]/59mLSilicon dioxide — 6 [hp_X]/59mLSodium sulfate — 6 [hp_X]/59mL
- Dosage form
- Liquid
- Route
- Oral
- Product type
- Over-the-counter drug
- Marketing category
- Unapproved homeopathic
- Marketing start
- Listing expires
- Other FDA classes
- Calcium (Chemical structure)Divalent (Chemical structure)Increased Coagulation Factor Activity (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Phosphate Chelating Activity (Mechanism)Potassium Compounds (Chemical structure)Potassium Compounds (Chemical structure)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
- Identifiers
- Product ID 63083-8013_a30db0d8-c531-4836-9d49-a76a02549fe6SPL ID a30db0d8-c531-4836-9d49-a76a02549fe6SPL set ID b3a33345-3c3d-4f86-ae4d-757c65fd1ed3UNII L11K75P92J, 660YQ98I10, E934B3V59H, 91GQH8I5F7, O3B55K4YKI, B7862WZ632, 451W47IQ8X, 1K573LC5TV, HF539G9L3Q, 70WT22SF4B, ETJ7Z6XBU4, 0YPR65R21J
- Pharmacologic class
- Blood Coagulation Factor; Calculi Dissolution Agent; Osmotic Laxative; Phosphate Binder; Potassium Salt
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N463083801302followed by a unit qualifier and the quantityPackage 63083-8013-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS Use according to standard homeopathic indications for self-limiting conditions. Common Materia Medica indications: colds, headaches, exhaustion, minor aches and pains.*
Excerpt only. Read the full label for complete information.